Evidence map›Paper›PMID 39165479›Full record

ReviewBrain communications2024

Integrative approach of omics and imaging data to discover new insights for understanding brain diseases.

Jong Hyuk Yoon, Hagyeong Lee, Dayoung Kwon, Dongha Lee, Seulah Lee, Eunji Cho, Jaehoon Kim, Dayea Kim

Abstract readReview
In one paragraph

Review in Brain communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jong Hyuk YoonNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.ORCID https://orcid.org/0000-0002-4090-3832
Hagyeong LeeNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.
Dayoung KwonNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.
Dongha LeeCognitive Science Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.
Seulah LeeNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.
Eunji ChoNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.
Jaehoon KimNeurodegenerative Diseases Research Group, Korea Brain Research Institute, Daegu 41062, Republic of Korea.
Dayea KimNew Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation (K-MEDI hub), Daegu 41061, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatments that can completely resolve brain diseases have yet to be discovered. Omics is a novel technology that allows researchers to understand the molecular pathways underlying brain diseases. Multiple omics, including genomics, transcriptomics and proteomics, and brain imaging technologies, such as MRI, PET and EEG, have contributed to brain disease-related therapeutic target detection. However, new treatment discovery remains challenging. We focused on establishing brain multi-molecular maps using an integrative approach of omics and imaging to provide insights into brain disease diagnosis and treatment. This approach requires precise data collection using omics and imaging technologies, data processing and normalization. Incorporating a brain molecular map with the advanced technologies through artificial intelligence will help establish a system for brain disease diagnosis and treatment through regulation at the molecular level.

Indexed as

brain diseasesgenomicsMRIPETproteomics

Identifiers

PMID39165479
PMCPMC11334939

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.